Rock Springs Capital Management LP Portfolio Holdings

Rock Springs Capital Management LP

  • $2.94 Billion
  • Q3 2024

Rock Springs Capital Management LP has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $2.94 Billion distributed in 109 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Unitedhealth Group Inc with a value of $172M, Intuitive Surgical Inc with a value of $133M, Argenx Se with a value of $127M, Eli Lilly & CO with a value of $126M, and Ultragenyx Pharmaceutical Inc. with a value of $110M.

Examining the 13F form we can see an decrease of $287M in the current position value, from $3.22B to 2.94B.

Rock Springs Capital Management LP is based out at Baltimore, MD

Below you can find more details about Rock Springs Capital Management LP portfolio as well as his latest detailed transactions.

Portfolio value $2.94 Billion
Healthcare: $2.88 Billion
Consumer Defensive: $61.1 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$1.19B
$16.9 Million 0.58% of portfolio
383,492
Q3 2024 Added 0.6%
$1.35B
$16.6 Million 0.56% of portfolio
461,028
Q2 2024 Added 2.04%
$239B
$15.7 Million 0.54% of portfolio
132,000
Q3 2024 Reduced 10.51%
$52.8M
$14.8 Million 0.51% of portfolio
1,746,449
Q3 2024 Added 12.31%
$2.8B
$14.8 Million 0.5% of portfolio
289,400
Q1 2024 New
$624M
$14 Million 0.48% of portfolio
756,931
Q2 2024 Added 0.53%
$2.68B
$13.4 Million 0.45% of portfolio
1,250,280
Q3 2024 Added 2.6%
$378B
$13 Million 0.44% of portfolio
80,000
Q3 2024 Reduced 52.94%
$524M
$12.3 Million 0.42% of portfolio
736,914
Q3 2024 Added 11.94%
$4.36B
$10.9 Million 0.37% of portfolio
206,108
Q3 2024 New
$561M
$10.5 Million 0.36% of portfolio
625,048
Q4 2023 Added 1.75%
$12B
$10.6 Million 0.36% of portfolio
151,000
Q2 2024 Added 1.46%
$155M
$10.4 Million 0.35% of portfolio
5,629,239
Q3 2024 Added 2.09%
$4.02B
$10.2 Million 0.35% of portfolio
55,861
Q3 2024 Reduced 47.09%
$1.29B
$8.65 Million 0.29% of portfolio
1,179,740
Q2 2024 Added 2.56%
$675M
$8.21 Million 0.28% of portfolio
650,000
Q3 2024 Reduced 3.7%
$132M
$7.71 Million 0.26% of portfolio
1,381,500
Q2 2024 Added 29.72%
$1.62B
$6.74 Million 0.23% of portfolio
605,013
Q3 2024 Reduced 53.2%
$2.25B
$6.4 Million 0.22% of portfolio
199,855
Q2 2024 New
$1.86B
$6.12 Million 0.21% of portfolio
249,923
Q2 2024 Added 69.43%
$879M
$6.02 Million 0.21% of portfolio
400,000
Q3 2024 Reduced 49.04%
$228M
$5.73 Million 0.2% of portfolio
691,300
Q3 2024 Added 5.96%
$197M
$5.76 Million 0.2% of portfolio
3,046,782
Q4 2023 Reduced 10.47%
$79.4M
$5.7 Million 0.19% of portfolio
2,300,059
Q4 2023 Reduced 18.22%
$700M
$4.32 Million 0.15% of portfolio
384,996
Q4 2023 Reduced 21.62%
$88.9M
$4 Million 0.14% of portfolio
1,568,000
Q3 2024 Added 6.31%
$72.3M
$4.1 Million 0.14% of portfolio
677,005
Q3 2023 Added 2.06%
$226M
$3.75 Million 0.13% of portfolio
1,032,988
Q1 2024 New
$205M
$3.47 Million 0.12% of portfolio
1,053,647
Q2 2024 Reduced 19.28%
$81.7M
$3.23 Million 0.11% of portfolio
3,266,960
Q3 2023 Added 196.92%
$217M
$3.11 Million 0.11% of portfolio
2,753,495
Q1 2024 Reduced 8.17%
$3.74B
$2.31 Million 0.08% of portfolio
80,000
Q3 2024 Reduced 43.14%
$98M
$2.3 Million 0.08% of portfolio
2,425,468
Q4 2023 Reduced 13.0%
$24.2M
$2.37 Million 0.08% of portfolio
3,003,259
Q2 2024 Added 108.45%
$136M
$1.83 Million 0.06% of portfolio
181,147
Q3 2023 Reduced 78.35%
$138M
$1.79 Million 0.06% of portfolio
989,990
Q2 2024 Reduced 23.26%
$48.1M
$1.6 Million 0.05% of portfolio
471,958
Q1 2022 New
$9.19M
$1.23 Million 0.04% of portfolio
2,609,125
Q4 2023 Reduced 4.36%
$91.5M
$780,000 0.03% of portfolio
1,200,409
Q2 2024 New
$245M
$616,000 0.02% of portfolio
160,217
Q3 2024 Reduced 93.0%
$4.03M
$642,000 0.02% of portfolio
891,719
Q4 2022 Reduced 19.56%
Neumora Therapeutics Inc.
-
$0 0.0% of portfolio
-
Q3 2024 Added 8.96%
Bicara Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Korro Bio Inc
-
$0 0.0% of portfolio
-
Q2 2024 New
Kyverna Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
Talphera Inc
-
$0 0.0% of portfolio
-
Q4 2022 New
Nevro Corp
-
$0 0.0% of portfolio
-
Q2 2020 New
Jasper Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Added 13.54%
-
$0 0.0% of portfolio
-
Q3 2024 New

Summary

  • Portfolio
  • No. of Stocks 109
  • Current Value $2.94 Billion
  • Prior Value $3.22 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 6 stocks
  • Additional Purchases 34 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 30 stocks
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email